1-15 of 15
Salim Kanoun
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with a PET-Guided Strategy in the Randomized Phase 3 Gained Study Conducted By Lysa

Vincent Camus, Thierry Jo Molina, Fabienne Desmots-Loyer, Amine Moslemi, Philippe Ruminy, Steven Le Gouill, Herve Ghesquieres, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Roch Houot, Catherine Thieblemont, Herve Maisonneuve, Fabien Claves, Krimo Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc-Matthieu Fornecker, Robin Noel, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Françoise Kraeber-Bodéré, Caroline Milin, Jean-Philippe Jais, Josette Briere, Olivier Casasnovas, Salim Kanoun, Emmanuel Itti, Paul Blanc-Durand, Mad-Hélénie Elsensohn, Loic Chartier, Fabrice Jardin, Thierry Fest
Journal: Blood
Blood (2024) 144 (Supplement 1): 575.
https://doi.org/10.1182/blood-2024-202446
Published: 2024
Journal Articles

Carmod, an Open-Label, Multicenter, Proof of Concept, Phase II Trial, Investigating the Safety and Efficacy of Golcadomide in Post-CART for Patients with Relapsed/Refractory High-Risk Aggressive Large B-Cell Lymphoma

Catherine Thieblemont, François-Xavier Gros, Sandrine Roulland, Salim Kanoun, Veronique Meignin, Celine Row, Thierry Lamy, Emmanuel Gomez, Karin Tarte, Gabriel Brisou
Journal: Blood
Blood (2024) 144 (Supplement 1): 7226.
https://doi.org/10.1182/blood-2024-207843
Published: 2024
Journal Articles

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

Clinical Trials & Observations
Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier, Salim Kanoun, Anne Claire Gac, Stéphanie Guidez, Mohamed Touati, Kamel Laribi, Franck Morschhauser, Christophe Bonnet, Agathe Waultier-Rascalou, Frédérique Orsini-Piocelle, Marc André, Marguerite Fournier, Fabienne Morand, Alina Berriolo-Riedinger, Barbara Burroni, Diane Damotte, Alexandra Traverse-Glehen, Philippe Quittet, Olivier Casasnovas
Journal: Blood
Blood (2024) 143 (11): 983–995.
https://doi.org/10.1182/blood.2023021564
Published: 2024
Includes: Supplemental data
Journal Articles

CD20low/CD68high a Promising Microenvironnement Profile Identifying Classical Hodgkin Lymphoma Patients with Poor Outcome a Lysa Study

Alexandra Traverse-Glehen, Laurent Martin, Camille Laurent, Peggy Dartigues, Barbara Burroni, Diane Damotte, Marie Parrens, Herve Ghesquieres, Marguerite Fournier, Salim Kanoun, Anne Ségolène Cottereau, Marc Andre, Cédric Rossi, René-Olivier Casasnovas
Journal: Blood
Blood (2023) 142 (Supplement 1): 3011.
https://doi.org/10.1182/blood-2023-174784
Published: 2023
Journal Articles

Low Tmtv Influences Response and Outcomes in R/R DLBCL 3L+ Patients Treated with CAR-T Cells : First Results of FDG-PET/CT Analysis in the French Descar-T Registry

Yassine Al Tabaa, Clément Bailly, Xavier Pallard, Anne Ségolène Cottereau, Jérémie Tordo, Pierre Sesques, Guillaume Cartron, Roch Houot, Roberta Di Blasi, Salim Kanoun, Caroline Milin, Françoise Kraeber-Bodéré, Laetitia Vercellino
Journal: Blood
Blood (2023) 142 (Supplement 1): 3019.
https://doi.org/10.1182/blood-2023-185794
Published: 2023
Journal Articles

Total Metabolic Tumor Volume and Tumor Dissemination Are Independent Prognostic Factors in Advanced Hodgkin Lymphoma

Salim Kanoun, Alina Berriolo-Riedinger, Anne Ségolène Cottereau, Veronique Edeline, Ilan Tal, Pauline Brice, Reda Bouabdallah, Herve Ghesquieres, Aspasia Stamatoullas-Bastard, Jehan Dupuis, Marc André, Thomas Gastinne, Julien Lazarovici, Samuel Griolet, Cedric Rossi, Michel Meignan, Rene-Olivier Casasnovas
Journal: Blood
Blood (2021) 138 (Supplement 1): 880.
https://doi.org/10.1182/blood-2021-147177
Published: 2021
Journal Articles

Final Analysis of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA) Using Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Patients over 60 Years with Advanced-Stage Classical Hodgkin Lymphoma

Herve Ghesquieres, Rene-Olivier Casasnovas, Emmanuelle Nicolas-Virelizier, Salim Kanoun, Gandhi Laurent Damaj, Vincent Delwail, Arnaud Jaccard, Kamel Laribi, Franck Morschhauser, Christophe Bonnet, Agathe Waultier, Frederique Orsini-Piocelle, Marc Andre, Marguerite Fournier, Fabienne Morand, Alina Berriolo-Riedinger, Diane Damotte, Alexandra Traverse-Glehen, Philippe Quittet, Pauline Brice
Journal: Blood
Blood (2021) 138 (Supplement 1): 1370.
https://doi.org/10.1182/blood-2021-152346
Published: 2021
Journal Articles

Amahrelis : Adcetris Maintenance after Autologous Stem Cell Transplantation in Hodgkin Lymphoma : A Real Life Study from Sfgmtc and Lysa Groups

Amira Marouf, Anne Ségolène Cottereau, MD, Guillemette Fouquet, MD, Salim Kanoun, MD, Patricia Franchi, MD, Romain Ricci, Michel Meignan, MD, David Sibon, MD PhD, Thomas Gastinne, MD, Cecile Borel, MD, Mohammad Hammoud, MD, Guillaume Sicard, MD, Romane Gille, Doriane Cavalieri, MD, Aspasia Stamatoulas Bastard, MD, Lauriane Clement-Filliatre, MD, Julien Lazarovici, MD, Adrien Chauchet, MD, Luc Mathieu Fornecker, MD PhD, Sandy Amorin, MD, Mathieu Roquet, Nicole Raus, Data Manager, Rene-Olivier Casasnovas, MD, Guillaume Cartron, MD PhD, Hervé Ghesquieres, MD PhD, Pauline Brice, MD, Olivier Hermine, Didier Bouscary, MDPhD, Marie Thérèse Rubio, MD PhD, Jerome Tamburini, MD PhD, Benedicte Deau Fischer
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-138666
Published: 2020
Journal Articles

Stage IIb High Risk Hodgkin Lymphoma Treated in the H10 and AHL2011 Trials: Similar Efficacy of Both Strategies and Prognostic Impact of Baseline Tmtv and PET2 Response

Cédric Rossi, MD PhD, Marc André, Clémentine Joubert, PhD, Catherine Fortpied, Pauline Brice, Bénédicte Deau-Fisher, MD, Herve Ghesquieres, MD PhD, Luc Mathieu Fornecker, MD PhD, Anne-Claire Gac, MD, Julien Lazarovici, Aspasia Stamatoullas, MD, John Raemakers, Massimo Federico, MD, Marie Maerevoet, MD, Sarah Bailly, MD, Salim Kanoun, MD, Michel Meignan, Anne Ségolène Cottereau, Rene-Olivier Casasnovas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 128.
https://doi.org/10.1182/blood-2019-125976
Published: 2019
Journal Articles

Efficacy of Chemotherapy or Chemo-Anti-PD-1 Combination after Unsatisfactory Response of Anti-PD-1 Therapy for Relapsed and Refractory Hodgkin Lymphoma: A Retrospective Series from Lysa Centers

Cédric Rossi, MD, Julia Gilhodes, Marie Maerevoet, MD, Charles Herbaux, Pauline Brice, MD, Sylvain Garciaz, Cecile Borel, MD, Loic Ysebaert, MD PhD, Lucie Oberic, MD, Julien Lazarovici, MD, Bénédicte Deau-Fisher, MD, Jehan Dupuis, MD, Adrien Chauchet, Julie Abraham, MD, Fontanet Bijou, Aspasia Stamatoullas-Bastard, Jean Valère Malfuson, Camille Golfier, Camille Laurent, MDPhD, Salim Kanoun, MD, Thomas Filleron, PhD, Rene-Olivier Casasnovas, MD, Hervé Ghesquières, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 652.
https://doi.org/10.1182/blood.V130.Suppl_1.652.652
Published: 2017
Journal Articles

Computational Integration to Model Tumor Dynamics in CLL Patients Treated with the Btk Inhibitor Ibrutinib (CompuTreatCLL): First Results of an Integrative Systems Biology Approach

Loic Ysebaert, MD PhD, Sarah Cadot, PhD, Salim Kanoun, MD, Soleakhena Ken, Christian Recher, MD PhD, François Malgouyres, Sebastien Gadat, Loic Dupre, PhD, Anne Quillet Mary, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2990.
https://doi.org/10.1182/blood.V130.Suppl_1.2990.2990
Published: 2017
Journal Articles

The Combination of High Expression of CD68-Positive Tumor-Associated Macrophages and PET2-Positivity Predicts Unfavorable Outcome in Patients with Classical Hodgkin Lymphoma Treated in the Lysa AHL2011 Study

Alexandra Traverse-Glehen, MD PhD, Diane Damotte, MD PhD, Peggy Dartigues, MD, Laurent Martin, MD PhD, Marie Parrens, MD PhD, Hervé Guesquieres, Clementine Sarkozy, Bénédicte Deau, MD, Reda Bouabdallah, MD, Sylvain Garciaz, MD, Michel Meignan, MD PhD, Véronique Edeline, MD, Salim Kanoun, MD, Alina Berriolo-Riedinger, MD, Pauline Brice, MD, Cedric Rossi, MD, Aspasia Stamatoullas, MD, Anne Sophie Veillard, Marc Andre, MD, Olivier Casasnovas, MD
Journal: Blood
Blood (2016) 128 (22): 1825.
https://doi.org/10.1182/blood.V128.22.1825.1825
Published: 2016
Journal Articles

Impact of 18 f-Fluoro-Deoxyglucose Positron Emission Tomography Imaging in the Management of Mantle Cell Lymphoma

Juliette Bouteloup, MD, Salim Kanoun, MD, Alina Berriolo-Riedinger, MD, Hervé Ghesquières, MD, Gilles A. Salles, MD PhD, Thérèse Gargi, Thomas Mognetti, MD, Emmanuelle Nicolas-Virelizier, MD, Amine Belhabri, MD, Rey Philippe, MD, Laurent Voillat, MD, Cedric Rossi, MD, Robin Noël, MD, Jean-Noel M. Bastie, MD PhD, Olivier Casasnovas, MD
Journal: Blood
Blood (2015) 126 (23): 3951.
https://doi.org/10.1182/blood.V126.23.3951.3951
Published: 2015
Journal Articles

Interim [18F]Fluorodeoxyglucosepositron Emission Tomography Suvmax Reduction Is Superior to Visual Analysis to Predict Early patient's Outcome in Hodgkin Lymphoma

Cedric Rossi, MD, Salim Kanoun, MD, Alina Berriolo-Riedinger, MD, Olivier Humbert, MD, Inna Dygay-Cochet, MD, Caroline Legouge, MD, Marie-Lorraine Chretien, M.D, Louis Berthet, MD, Jean-Noel Bastie, MD, PhD, Rene-Olivier Casasnovas, MD
Journal: Blood
Blood (2012) 120 (21): 3630.
https://doi.org/10.1182/blood.V120.21.3630.3630
Published: 2012
Journal Articles

Metabolic Tumor Volume Is an Independent Prognosis Factor Predicting patient's Outcome in Hodgkin Lymphoma

Salim Kanoun, MD, Cedric Rossi, MD, Alina Berriolo-Riedinger, MD, Olivier Humbert, MD, Inna Dygay-Cochet, MD, Marie-Lorraine Chretien, M.D, Caroline Legouge, MD, Louis Berthet, MD, Jean-Noel Bastie, MD, PhD, Rene-Olivier Casasnovas, MD
Journal: Blood
Blood (2012) 120 (21): 3631.
https://doi.org/10.1182/blood.V120.21.3631.3631
Published: 2012